Compare NCNO & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NCNO | STAA |
|---|---|---|
| Founded | 2011 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Ophthalmic Goods |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2022 | 1995 |
| Metric | NCNO | STAA |
|---|---|---|
| Price | $16.55 | $23.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 9 |
| Target Price | ★ $26.07 | $22.81 |
| AVG Volume (30 Days) | ★ 3.3M | 898.6K |
| Earning Date | 05-27-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 115.15 | N/A |
| EPS | ★ 0.12 | 0.10 |
| Revenue | ★ $594,781,000.00 | $239,442,000.00 |
| Revenue This Year | $9.53 | $30.82 |
| Revenue Next Year | $8.97 | $8.41 |
| P/E Ratio | ★ $135.17 | $241.90 |
| Revenue Growth | ★ 10.01 | N/A |
| 52 Week Low | $13.80 | $15.59 |
| 52 Week High | $33.92 | $35.87 |
| Indicator | NCNO | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 48.29 | 33.08 |
| Support Level | $14.04 | $16.49 |
| Resistance Level | $17.22 | $27.53 |
| Average True Range (ATR) | 0.77 | 1.48 |
| MACD | -0.16 | -0.42 |
| Stochastic Oscillator | 17.15 | 7.92 |
Ncino Inc is a provider of cloud-based software for financial institutions. It is focused on developing the nCino Platform to transform commercial and small business lending for community and regional banks in the U.S. With the company's platform financial institutions can Operate More Intelligently, Improve Efficiency, Elevate Employee and Client Experiences, and Manage Risk and Compliance Continuously Rather Than Reactively. It has built and acquired technology, including SimpleNexus, DocFox, FullCircl, ILT, Visible Equity, FinSuite, and Sandbox Banking, to augment the nCino Platform's capabilities for mortgage lending, onboarding, account opening, indirect auto lending, and analytics and AI. The company operates as one operating segment.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.